Lipid nanoparticles for administration of poorly water soluble neuroactive drugs.

about

Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs

P2860

Q58032213-D4B3829C-8DD0-4F1C-A506-C0FBEB408FDE

P2860

Lipid nanoparticles for administration of poorly water soluble neuroactive drugs.

Item

http://www.wikidata.org/entity/Q48034195

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Lipid nanoparticles for administration of poorly water soluble neuroactive drugs.

@en

Lipid nanoparticles for administration of poorly water soluble neuroactive drugs.

@nl

type

Item

label

Lipid nanoparticles for administration of poorly water soluble neuroactive drugs.

@en

Lipid nanoparticles for administration of poorly water soluble neuroactive drugs.

@nl

prefLabel

Lipid nanoparticles for administration of poorly water soluble neuroactive drugs.

@en

Lipid nanoparticles for administration of poorly water soluble neuroactive drugs.

@nl

P1476

Lipid nanoparticles for administration of poorly water soluble neuroactive drugs

@en

P2093

Francesca Melancia

http://www.w3.org/2001/XMLSchema#string

Markus Drechsler

http://www.w3.org/2001/XMLSchema#string

Michela Servadio

http://www.w3.org/2001/XMLSchema#string

Rita Cortesi

http://www.w3.org/2001/XMLSchema#string

Viviana Trezza

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid.

Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids.

Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy.

Characteristics of compounds that cross the blood-brain barrier

Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview.

Endogenous cannabinoid release within prefrontal-limbic pathways affects memory consolidation of emotional training.

Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats.

Progesterone treatment reduces neuroinflammation, oxidative stress and brain damage and improves long-term outcomes in a rat model of repeated mild traumatic brain injury.

Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats.

Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597).

P2888

s10544-017-0188-x

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10544-017-0188-X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28526975

http://www.w3.org/2001/XMLSchema#string

Lipid nanoparticles for administration of poorly water soluble neuroactive drugs.

about

P2860

P2860

Lipid nanoparticles for administration of poorly water soluble neuroactive drugs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698